The abstract is read at the publisher; the summary is JClub's.
In db/db mice, resveratrol attenuates diabetic kidney disease by inducing E2f7 and E2f8, which suppress E2f1-driven tubular senescence.
- Why it matters: Renal senescence is a key feature of DKD, but the transcriptional control linking hyperglycemia to senescent programs is not well defined.
- What they did: Hyperglycemic conditions upregulate E2f1 in mouse renal tubular epithelial cells, and E2f1 knockdown in vivo ameliorates DKD pathology; resveratrol increases E2f7/E2f8 that bind the E2F1 promoter to repress transcription.
- The result: This E2F1–E2F7/8 regulatory loop is linked to reduced DNA damage and senescence, suggesting a therapeutic target for DKD.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.